Does AFATINIB Cause Non-small cell lung cancer? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Non-small cell lung cancer have been filed in association with AFATINIB (Gilotrif). This represents 0.8% of all adverse event reports for AFATINIB.
48
Reports of Non-small cell lung cancer with AFATINIB
0.8%
of all AFATINIB reports
15
Deaths
6
Hospitalizations
How Dangerous Is Non-small cell lung cancer From AFATINIB?
Of the 48 reports, 15 (31.3%) resulted in death, 6 (12.5%) required hospitalization, and 2 (4.2%) were considered life-threatening.
Is Non-small cell lung cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AFATINIB. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does AFATINIB Cause?
Diarrhoea (2,001)
Malignant neoplasm progression (1,622)
Rash (808)
Stomatitis (468)
Death (443)
Nausea (430)
Decreased appetite (412)
Vomiting (381)
Paronychia (344)
Dehydration (323)
What Other Drugs Cause Non-small cell lung cancer?
SOTORASIB (483)
CARBOPLATIN (431)
BRIGATINIB (370)
NIVOLUMAB (366)
PACLITAXEL (275)
IPILIMUMAB (273)
PEMETREXED (234)
CERITINIB (183)
CRIZOTINIB (178)
AMG-510 (134)
Which AFATINIB Alternatives Have Lower Non-small cell lung cancer Risk?
AFATINIB vs AFINITOR
AFATINIB vs AFLIBERCEPT
AFATINIB vs AGALSIDASE ALFA
AFATINIB vs AGALSIDASE BETA
AFATINIB vs AGOMELATINE